[{"id":360,"public_id":26,"key":"uljf21","name":"Gubin_2018","description":"TILs from sarcoma after aPD1 and/or aCTLA4 immunotherapy mouse tumor (T3 MCA sarcoma)","ref_id":1,"project_attrs":{"tissue":"tumor (sarcoma)","timepoints":"11 days after tumor establishment"},"nber_samples":4,"created_at":"2021-08-13T12:12:51.934Z","updated_at":"2026-06-16T14:03:09.667Z","url":"http://spica.unil.ch/projects/360.json"},{"id":358,"public_id":23,"key":"ynt5ce","name":"Ekiz_2019","description":"Effect of miR-155 KO in T cells from melanoma ","ref_id":1,"project_attrs":{"condition":"melanoma (B16)","timepoints":"9-12 days after tumor injection"},"nber_samples":2,"created_at":"2021-08-13T08:56:15.939Z","updated_at":"2026-06-17T02:56:09.089Z","url":"http://spica.unil.ch/projects/358.json"},{"id":351,"public_id":17,"key":"ryyfy0","name":"Bassez_2021","description":"TILs from Responders and Non-Responders to ICB in breast cancer patients.","ref_id":1,"project_attrs":{"timepoints":"pre-treatment","tissue":"tumor (breast carcinoma)","condition":"breast carcinoma"},"nber_samples":2,"created_at":"2021-08-11T12:48:20.768Z","updated_at":"2026-06-16T14:17:15.585Z","url":"http://spica.unil.ch/projects/351.json"},{"id":352,"public_id":7,"key":"povozy","name":"Andreatta_2019","description":"T cells from (MC38) tumor-draining lymph nodes","ref_id":1,"project_attrs":{"tissue":"lymph node","timepoints":"14-19 days post tumor engraftment","condition":"MC38 colon adenocarcinoma"},"nber_samples":1,"created_at":"2021-08-11T12:49:22.961Z","updated_at":"2026-06-16T17:09:00.004Z","url":"http://spica.unil.ch/projects/352.json"},{"id":348,"public_id":6,"key":"b4s78z","name":"SadeFeldman_2019","description":"TILs from Responders and Non-Responders to ICB in melanoma patients","ref_id":1,"project_attrs":{"tissue":"tumor","timepoints":"pre-treatment","condition":"melanoma"},"nber_samples":2,"created_at":"2021-08-11T12:31:40.307Z","updated_at":"2026-06-17T13:05:58.343Z","url":"http://spica.unil.ch/projects/348.json"},{"id":339,"public_id":5,"key":"4vmfqk","name":"Wei_2019","description":"WT vs Regnase KO CD8 TILs (sgRNA transduced OT-I cells)","ref_id":1,"project_attrs":{"tissue":"tumor","condition":"melanoma (B16)","timepoints":"7 days after T cells adoptive transfer"},"nber_samples":4,"created_at":"2021-08-11T10:46:43.156Z","updated_at":"2026-06-16T20:28:19.075Z","url":"http://spica.unil.ch/projects/339.json"},{"id":338,"public_id":4,"key":"cghndc","name":"Miller_2019","description":"tumor-specific CD8 TILs (tetramer sorted) from B16-OVA tumors","ref_id":1,"project_attrs":{"tissue":"tumor","condition":"melanoma (B16)","timepoints":"10 days post tumor engraftment"},"nber_samples":1,"created_at":"2021-08-11T09:50:51.737Z","updated_at":"2026-06-16T11:40:57.815Z","url":"http://spica.unil.ch/projects/338.json"},{"id":335,"public_id":2,"key":"mru9ct","name":"Carmona_2019","description":"CD8 TILs from B16 melanoma tumors","ref_id":1,"project_attrs":{"tissue":"tumor","timepoints":"15 day post tumor engraftment","condition":"melanoma (B16)"},"nber_samples":3,"created_at":"2021-08-11T08:36:36.243Z","updated_at":"2026-06-16T12:02:02.565Z","url":"http://spica.unil.ch/projects/335.json"}]